RedHill Biopharma (RDHL) Current Assets (2012 - 2025)
RedHill Biopharma (RDHL) posted quarterly Current Assets of $6.5 million for Q4 2025, down 45.19% year-over-year from $11.9 million in Q4 2024, and down 48.0% quarter-over-quarter from $12.6 million in Q2 2025.
RedHill Biopharma (RDHL) Current Assets (2012 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Current Assets for 14 consecutive years, with $6.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 45.19% year-over-year to $6.5 million; the TTM figure through Dec 2025 stood at $6.5 million (down 45.19% YoY), while the FY2025 annual figure was $6.5 million, down 45.19% from the prior year.
- Current Assets slipped to $6.5 million in Q4 2025 per RDHL's latest filing, from $12.6 million in the prior quarter.
- Across five years, Current Assets topped out at $98.5 million in Q2 2021 and bottomed at $6.5 million in Q4 2025.
- Historically, Current Assets has averaged $45.5 million across 5 years, with a median of $21.6 million in 2023.
- Annual changes were most pronounced in 2021 — Current Assets soared 61.13% — and 2023, when it tumbled 81.21%.
- RedHill Biopharma's Current Assets stood at $89.2 million in 2021, then retreated by 3.65% to $85.9 million in 2022, then sank by 81.21% to $16.1 million in 2023, then slipped by 26.2% to $11.9 million in 2024, then plunged by 45.19% to $6.5 million in 2025.
- Business Quant data shows RDHL's Current Assets at $6.5 million in Q4 2025, $12.6 million in Q2 2025, and $11.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 6.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.53 Mn |
| Jun 30, 2025 | 12.56 Mn |
| Dec 31, 2024 | 11.91 Mn |
| Jun 30, 2024 | 15.70 Mn |
| Dec 31, 2023 | 16.14 Mn |
| Jun 30, 2023 | 27.05 Mn |
| Dec 31, 2022 | 85.90 Mn |
| Jun 30, 2022 | 91.27 Mn |
| Dec 31, 2021 | 89.15 Mn |
| Jun 30, 2021 | 98.49 Mn |
| Dec 31, 2020 | 70.50 Mn |
| Jun 30, 2020 | 61.13 Mn |
| Dec 31, 2019 | 53.21 Mn |
| Jun 30, 2019 | 39.97 Mn |
| Dec 31, 2018 | 56.79 Mn |
| Jun 30, 2018 | 32.22 Mn |
| Mar 31, 2018 | 40.74 Mn |
| Dec 31, 2017 | 51.68 Mn |
| Dec 31, 2016 | 67.82 Mn |
| Mar 31, 2015 | 34.90 Mn |